MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Indeglitazar

CAS No. : 835619-41-5

MCE 站：Indeglitazar

产品活性：Indeglitazar (PPM 204) 是一种具有口服活性的 PPAR 泛激动剂，对 PPARα，PPARδ 和 PPARγ 都有作用活性。

研究领域：Cell Cycle/DNA Damage

作用靶点：PPAR

In Vitro: In an assay of preadipocyte differentiation, measuring in part functional insulin sensitization capability of the cells, Indeglitazar shows an EC₅₀ of 0.32 μM compared with Rosiglitazone, which shows an EC₅₀ of 13 nM, although the maximal response obtained from the 2 compounds is comparable.

In Vivo: An initial assessment of in vivo activity is carried out using the Zucker rat model of diabetes. The significant lowering of glucose, HbA_1C, triglycerides, and total cholesterol are observed after i.v. treatment with 10 mg/kg Indeglitazar once per day for 3 weeks. Notably, the level of Adiponectin (on day 21) is essentially unchanged in treated vs. untreated animals (4.8 mcg/mL vs. 4.9 mcg/mL), thus the observed reductions in glucose and HbA_1C are achieved in an adiponectin-independent fashion. These differences in the effects of Indeglitazar in vivo may be a consequence of synergy between the 3 PPAR activities or because of the SPPARM profile of the compound, or a combination of these factors. The oral activity of Indeglitazar is assessed in the ob/ob model of diabetes and insulin resistance. Indeglitazar significantly decreases glucose, insulin, triglycerides, and free fatty acid levels.

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Cell Cycle/DNA Damage Compound Library  |  Clinical Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Diabetes Related Compound Library  |  Anti-COVID-19 Compound Library  |  Orally Active Compound Library  |  Retinoic acid  |  Rosiglitazone  |  GW9662  |  GW6471  |  Pioglitazone  |  Fenofibrate  |  T0070907  |  Troglitazone  |  Fisetin  |  GW 501516  |  Pirinixic acid  |  5-Aminosalicylic Acid  |  Daidzein  |  GW1929  |  Naringenin  |  Icariin  |  MK-886  |  GW7647  |  Bezafibrate  |  GSK3787  |  GW0742  |  Astaxanthin  |  FH535  |  Magnolol  |  Gemfibrozil  |  Seladelpar sodium salt  |  Palmitelaidic Acid  |  Eupatilin

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。